ChenGuang Biotech Group Co., Ltd. Stock

Equities

300138

CNE100000WC5

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
10.06 CNY +0.40% Intraday chart for ChenGuang Biotech Group Co., Ltd. +0.90% -25.09%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 7.24B 1B Sales 2025 * 8.5B 1.18B Capitalization 5.16B 714M
Net income 2024 * 393M 54.44M Net income 2025 * 629M 87.14M EV / Sales 2024 * 0.92 x
Net Debt 2024 * 1.52B 211M Net Debt 2025 * 1.32B 183M EV / Sales 2025 * 0.76 x
P/E ratio 2024 *
13.6 x
P/E ratio 2025 *
8.52 x
Employees 1,799
Yield 2024 *
1.7%
Yield 2025 *
2.15%
Free-Float 22.51%
More Fundamentals * Assessed data
Dynamic Chart
ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI
ChenGuang Biotech Group Co., Ltd. commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on November 17, 2023. CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
US targets two China-based firms over forced labor practices -DHS RE
Chenguang Biotech Group Co., Ltd. Announces Management Appointment CI
ChenGuang Biotech Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 17 May 2023 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day+0.40%
1 week+0.90%
Current month+6.46%
1 month+3.18%
3 months-14.96%
6 months-27.21%
Current year-25.09%
More quotes
1 week
9.76
Extreme 9.76
10.99
1 month
8.90
Extreme 8.9
10.99
Current year
8.90
Extreme 8.9
13.49
1 year
8.90
Extreme 8.9
18.69
3 years
8.90
Extreme 8.9
19.36
5 years
6.45
Extreme 6.45
21.79
10 years
3.51
Extreme 3.5119
21.79
More quotes
Managers TitleAgeSince
Founder 42 00-04-11
Chief Executive Officer 65 00-04-11
Director/Board Member 39 08-11-30
Members of the board TitleAgeSince
Chief Executive Officer 65 00-04-11
Founder 42 00-04-11
Director/Board Member 49 05-11-30
More insiders
Date Price Change Volume
24-05-14 10.06 +0.40% 8 165 600
24-05-14 10.02 -0.99% 7,653,484
24-05-13 10.12 -4.80% 15,125,980
24-05-10 10.63 +3.20% 20,792,000
24-05-09 10.3 +2.08% 13,490,480

End-of-day quote Shenzhen S.E., May 14, 2024

More quotes
Chenguang Biotech Group Co., Ltd. is a China-based company principally engaged in the manufacture and sales of natural pigment extracts, natural spices extracts, essential oil extracts, natural supplement and medicine extracts, fat and protein and others. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The Company distributes its products in domestic and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
10.06 CNY
Average target price
14.42 CNY
Spread / Average Target
+43.31%
Consensus
  1. Stock Market
  2. Equities
  3. 300138 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW